banking on a strong performance of the WATCHMAN left atrial appendage closure device. It is the first device to offer a non-pharmacologic alternative to oral anticoagulants that has been studied in a ...

Boston Scientific’s Watchman left atrial appendage (LAA) closure device to prevent stroke resulted in significantly less bleeding after an ablation procedure than taking blood thinners ...

establishing uniform coverage for percutaneous left atrial appendage closure (LAAC) devices such as the Watchman procedure. However, individuals must meet specific criteria. Learn more about the ...

They randomly assigned 803 patients to left atrial appendage closure with the Watchman FLX device and 797 patients to oral anticoagulation therapy from November 2019 through June 2021. Mean ...

Medicare has requirements an individual must meet to qualify for left atrial appendage closure devices, and the Watchman implant device is a type of atrial appendage closure device. Medicare parts ...

Boston Scientific has reported positive three-year data from the OPTION global trial of the WATCHMAN FLX left atrial appendage closure (LAAC) device in individuals with atrial fibrillation ...

SHREVEPORT, La. (KTAL/KMSS) — CHRISTUS Shreveport-Bossier Health System have announced their 500th successful implant of a breakthrough cardiac procedure that can reduce the risk of a stroke.

AHA 2024 4 Reasons to Question Percutaneous LAAC After AF Ablation The OPTION trial of Watchman after ablation ... the rise in percutaneous left atrial appendage closure procedures.